Key Learnings from the Axendia Study and the Future of Product Quality in Life Sciences
A recent research study by Axendia revealed that in the vast majority of Life Science companies, Quality Management Systems were installed as silos with little integration to operational systems. Major results from the study further imply that this siloed approach is a major barrier to managing the containment, enforcement, and disposition of product when adverse event occur, especially across multi-site, global enterprises. One of the more alarming findings from the study reveals that 93% of respondents report recurrences of quality issues after closing a CAPA.
In this webinar, understand the implications for the future of product quality approaches in Life Sciences.
Hear our experts’ views on:
• Achieving “Closed-Loop Quality,” and the characteristics that are showing true advances in product quality throughout the product life cycle
• Breaking down quality silos to foster collaboration across functional boundaries and systems to reduce wasteful practices
• Speeding innovation by creating a collaborative product quality process – from product design, to supply, to manufacturing, to customer use
• Rapidly identifying root causes by creating a central knowledge base of Product Design, Process Design, Manufacturing (As-Built and Inspection), Field Use and Quality Event data
• Gaining complete visibility into distributed operations, with intelligence to understand the global impact of local events, and coordination of quality actions and best practices across the enterprise.
• Notable results from companies that have adopted these practices.
Speakers:
Daniel R. Matlis, President, Axendia
Julie Newsome, Director of Quality, Carl Zeiss Meditec
Karim Lokas, VP Product Strategy, Camstar Systems
Learn More